Literature DB >> 11866825

Determination of in vitro postantibiotic effects in Staphylococcus aureus and Escherichia coli by [3H]thymidine incorporation.

Magnús Gottfredsson1, Helga Erlendsdóttir, Adalsteinn Gudmundsson, Sigurdur Gudmundsson.   

Abstract

Postantibiotic effects (PAE) and control-related effective regrowth time (CERT) of dicloxacillin, vancomycin, rifampin and gentamicin in Staphylococcus aureus and imipenem, gentamicin, tobramycin, doxycycline and rifampin in Escherichia coli were measured by standard viability counting and [3H]thymidine incorporation. For PAE determination, the two methods correlated well; r2=0.821 for S. aureus and r2=0.939 for E. coli. For viable counts below the detection limits of 105 to 106 log10 CFU/mL, the PAE was overestimated by the [3H]thymidine method. Quantitation of CERT by both methods showed a good correlation, r2=0.867 for S. aureus and r2=0.997 for E. coli. Measuring [3H]thymidine incorporation in bacteria is a novel alternative method for the determination of PAE and CERT.

Entities:  

Year:  1996        PMID: 11866825     DOI: 10.1111/j.1469-0691.1996.tb00213.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.

Authors:  Margareta Svensson; Lennart E Nilsson; Magnus Ström; Maud Nilsson; Mikael Sörberg
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.

Authors:  J G den Hollander; K Fuursted; H A Verbrugh; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Pharmacodynamic effects of antibiotics and acid pump inhibitors on Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.